It is now thought that the critical property of bone is strength rather than weight, and that control of bone strength is mainly exercised through the effect of the mechanical loads brought to bear on bone. Muscle contraction places the greatest physiological load on bone, and so the strength of bone must be adapted to muscle strength (the functional muscle-bone unit). The Utah paradigm of skeletal physiology [J Hum Biol 1998;10:599–605] provides a model of bone development that describes how bone structure is regulated by local mechanical effects that can be adjusted by the effects of hormones. The DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed) study analysed the interaction between the muscle and bone systems in males and females before and during puberty. This study found that differences between the genders in bone adaptation during puberty are at least partly driven by the influence of oestrogen in females. Testosterone seems to have no direct relevant effect on bone during puberty, but may be implicated in the greater amount of muscle mass achieved in boys compared with girls.

Keywords:
Bone development, Bone strength, Muscle strength, Muscle-bone unit, Oestrogen, Puberty
1.
Schönau E: The peak bone mass concept: is it still relevant? Pediatr Nephrol 2004;19:828–831.
2.
Parfitt AM: The two faces of growth: benefits and risks to bone integrity. Osteoporos Int 1994;4:382–398.
3.
Rauch F, Schoenau E: The developing bone: slave or master of its cells and molecules? Pediatr Res 2001;50:309–314.
4.
Frost HM: Skeletal structural adaptations to mechanical usage (SATMU). 1:Redefining Wolff’s law: the bone modelling problem. Anat Rec 1990;226:403–413.
5.
Frost HM: Skeletal structural adaptations to mechanical usage (SATMU). 2:Redefining Wolff’s law: the remodelling problem. Anat Rec 1990;226:414–422.
6.
Frost HM: Changing concepts in skeletal physiology: Wolff’s law, the mechanostat and the ‘Utah paradigm’. J Hum Biol 1998;10:599–605.
7.
Frost HM: Perspectives: a proposed general model of the mechanostat (suggestions from a new paradigm). Anat Rec 1996;244:139–147.
8.
Frost HM: The Utah paradigm of skeletal physiology: an overview of its insights for bone, cartilage and collagenous tissue organs. J Bone Miner Metab 2000;18:305–316.
9.
Frost HM, Schönau E: The ‘muscle-bone unit’ in children and adolescents: a 2000 overview. J Pediatr Endocrinol Metab 2000;13:571–590.
10.
Frost HM: The Utah paradigm of skeletal physiology: what is it? Vet & Compar Orthop & Trauma 2001;14:179–184.
11.
Frost HM: Why should many skeletal scientists and clinicians learn the Utah paradigm of skeletal physiology? J Musculoskelet Neuronal Interact 2001;2:121–130.
12.
Schoenau E, Frost HM: The ‘muscle-bone unit’ in children and adolescents. Calcif Tissue Int 2002;70:405–407.
13.
Schönau E, Schwahn B, Rauch F: The muscle-bone relationship: methods and management – perspectives in glycogen storage disease. Eur J Pediatr 2002;161:S50–S52.
14.
Schoenau E, Neu CM, Beck B, Manz F, Rauch F: Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res 2002;17:1095–1101.
15.
Schoenau E: The ‘functional muscle-bone unit’: a two-step diagnostic algorithm in pediatric bone disease. Pediatr Nephrol 2005;20:356–359.
16.
Frost HM: Bone ‘mass’ and the ‘mechanostat’: a proposal. Anat Rec 1987;219:1–9.
17.
Qin L, Mak AT, Cheng CW, Hung LK, Chan KM: Histomorphological study on pattern of fluid movement in cortical bone in goats. Anat Rec 1999;255:380–387.
18.
Aarden EM, Burger EH, Nijweide PJ: Function of osteocytes in bone. J Cell Biochem 1994;55:287–299.
19.
Schoenau E, Saggese G, Peter F, Baroncelli GI, Shaw NJ, Crabtree NJ, Zadik Z, Neu CM, Noordam C, Radetti G, Hochberg Z, on behalf of the European Society for Paediatric Endocrinology (ESPE) Bone Club: From bone biology to bone analysis. Horm Res 2004;61:257–269.
20.
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR: Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMHR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987;2:595–610.
21.
Schiessl H, Frost HM, Jee WSS: Estrogen and bone-muscle strength and mass relationships. Bone 1998;22:1–6.
22.
Zanchetta JR, Plotkin H, Alvarez Filgueira ML: Bone mass in children: normative values for the 2–20-year-old population. Bone 1995;16(suppl 1):S393–S399.
23.
Wang L, McMahan CA, Banu J, Okafor MC, Kalu DN: Rodent model for investigating the effects of estrogen on bone and muscle relationship during growth. Calcif Tissue Int 2003;72:151–155.
24.
Frost HM: The mechanostat: a proposed pathogenetic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner 1987;2:73–85.
25.
Järvinen TLN, Kannus P, Sievänen H: Estrogen and bone – a reproductive and locomotive perspective. J Bone Miner Res 2003;18:1921–1931.
26.
Rico H, Revilla M, Villa LF, Ruiz-Contreras D, Hernandez ER, Alvarez de Buergo M: The four-compartment models in body composition: data from a study with dual-energy X-ray absorptiometry and near-infrared interactance on 815 normal subjects. Metabolism 1994;43:417–422.
27.
Neu CM, Manz F, Rauch F, Merkel A, Schoenau E: Bone densities and bone size at the distal radius in healthy children and adolescents: a study using peripheral quantitative computed tomography. Bone 2001;28:227–232.
28.
Neu CM, Rauch F, Manz F, Schoenau E: Modeling of cross-sectional bone size, mass and geometry at the proximal radius: a study of normal bone development using peripheral quantitative computed tomography. Osteoporos Int 2001;12:538–547.
29.
Rauch F, Tutlewski B, Schoenau E: Peripheral quantitative computed tomography at the distal radius: cross-calibration between two scanners. J Musculoskelet Neuronal Interact 2001;2:153–155.
30.
Schoenau E, Neu CM, Mokov E, Wassmer G, Manz F: Influence of puberty on muscle area and cortical bone area of the forearm in boys and girls. J Clin Endocrinol Metab 2000;85:1095–1098.
31.
Schoenau E, Neu CM, Rauch F, Manz F: The development of bone strength at the proximal radius during childhood and adolescence. J Clin Endocrinol Metab 2001;86:613–618.
32.
Schoenau E, Neu CM, Rauch F, Manz F: Gender-specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone 2002;31:110–113.
33.
Schoenau E, Neu MC, Manz F: Muscle mass during childhood – relationship to skeletal development. J Musculoskelet Neuronal Interact 2004;4:105–108.
34.
Neu CM, Rauch F, Rittweger J, Manz F, Schoenau E: Influence of puberty on muscle development at the forearm. Am J Physiol Endocrinol Metab 2002;283:E103–E107.
35.
Rauch F, Schönau E: Peripheral quantitative computed tomography of the distal radius in young subjects – new reference data and interpretation of results. J Musculoskelet Neuronal Interact 2005;5:119–126.
36.
Specker BL, Schoenau E: Quantitative bone analysis in children: current methods and recommendations. J Pediatr 2005;146:726–731.
37.
Frost HM: On the estrogen-bone relationship and postmenopausal bone loss: a new model. J Bone Miner Res 1999;14:1473–1477.
38.
Katzman DK, Bachrach LK, Carter DR, Marcus R: Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991;73:1332–1339.
39.
Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E: The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest 1999;104:795–804.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.